Skip to content

Discontinued — last reported Q3 '22

EPS (Diluted) at other companies

Abbott logo
AbbottABT
$0.61-19.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.14-52.9%
Boston Scientific logo
Boston ScientificBSX
$0.90+100%
Medtronic logo
MedtronicMDT
$0.97+18.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$0.68+38.8%
ITG
Integer HoldingsITGR
$0.48+173%

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.8B+38.4%
Enterprise value$1.73B+48.1%
P/S2,391.5×

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed November 10, 2022, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s EPS (diluted)?
Pulse Biosciences, Inc. (PLSE) reported EPS (diluted) of -$0.49 in Q3 2022.
How has Pulse Biosciences, Inc.'s EPS (diluted) changed year-over-year?
Pulse Biosciences, Inc.'s EPS (diluted) decreased by 2.1% year-over-year, from -$0.48 to -$0.49.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.